• Canagliflozin Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Stability Tablet, packed in secure, moisture-resistant Alu-Alu blister strips.

    Active IngredientStrengthPrimary Clinical Function
    Canagliflozin (Hemi-hydrate) USP100 mgThe Metabolic Anchor: Standard starting dose for glycemic control and cardio-renal protection.
    Canagliflozin (Hemi-hydrate) USP300 mgThe High-Efficacy Payload: Utilized for patients requiring maximal HbA1c reduction with preserved renal function.
    ExcipientsProprietary MatrixLactose-Optimized Blend: Engineered to ensure rapid disintegration and 100% bioequivalence to the innovator brand.
  • DAPAGLIFLOZIN TABLETS

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Hydrolytically Shielded Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive propanediol monohydrate active ingredient.

    Active IngredientStrengthPrimary Clinical Function
    Dapagliflozin (as Propanediol Monohydrate) USP/Ph.Eur.5 mgThe Titration & Hepatic Anchor: The definitive starting dose utilized for patients with severe hepatic impairment or those at high risk for volume depletion (hypotension).
    Dapagliflozin (as Propanediol Monohydrate) USP/Ph.Eur.10 mgThe Cardio-Renal Macrodose: The massive, globally standardized therapeutic payload required for the aggressive, daily maintenance of Heart Failure, CKD, and Type 2 Diabetes.
    ExcipientsMicrocrystalline Cellulose / Anhydrous Lactose / Crospovidone / Silicon Dioxide / Magnesium Stearate / Premium Polymeric FilmDiluent / Densifier / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing Strict Low-Humidity Granulation to prevent the highly sensitive API from degrading during compression, sealed with an impenetrable film-coat to block environmental moisture and ensure rapid gastric dissolution)

    *Pack Sizes: 10×10 Alu-Alu Blisters or 14/28-Tablet Calendar Packs (Optimized specifically for strict chronic cardio-renal dispensing regimens).

  • Teneligliptin 20Mg + Metformin 500Mg Tablet Sustained Release

    Free

    Teneligliptin 20mg + Metformin 500mg Sustained Release (SR) tablet is a combination antidiabetic medication used to manage type 2 diabetes mellitus when diet and exercise alone are insufficient.

  • Teneligliptin Tablet

    Free

    Teneligliptin 20mg tablet is a modern oral antidiabetic medication belonging to the DPP-4 inhibitor (dipeptidyl peptidase-4) class, used primarily to manage type 2 diabetes mellitus.

  • Vildagliptin & Metformin Tablet

    Free

    Vildagliptin and Metformin combination tablets are fixed-dose oral anti-diabetic medications containing two active substances: Vildagliptin (a DPP-4 inhibitor) and Metformin Hydrochloride (a biguanide). These are primarily used to improve blood sugar control in adults with type 2 diabetes.

  • Vildagliptin Tablets

    Free

    Vildagliptin tablets contain vildagliptin as the active ingredient, typically in a 50 mg strength. It is an oral anti-diabetic medication belonging to the dipeptidyl peptidase-4 (DPP-4) inhibitor class, used to improve glycaemic control in adults with type 2 diabetes.

  • Voglibose & Metformin (SR) Tablets

    Free

    Voglibose and Metformin tablets typically contain Voglibose and Metformin Hydrochloride as the primary active ingredients. This combination is a standard treatment for type 2 diabetes mellitus to manage blood sugar levels.

  • Voglibose Tablet

    Free

    Voglibose tablets are oral anti-diabetic medications primarily composed of the active ingredient Voglibose, a synthetic alpha-glucosidase inhibitor. They are typically available in strengths of 0.2 mg or 0.3 mg.